Last updated: 2026-09-22 20:48:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Apnimed, Inc. (APMD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $25,51, with a market capitalization of $1,21B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $16,12 to $35,29. This page covers its latest market performance, valuation, price trends and company information.
$1,21B | |
$26,41 | |
$35,29 | |
$16,12 | |
$26,22 | |
538,75K | |
558,69K | |
-- | |
$35,29 | |
$16,12 | |
-- | |
-- |
Apnimed, Inc. (APMD) is trading at $25,51 in after-hours trading as of 2026-09-22 19:57:53, down 2,73% ($0,71) from the regular-session close of $26,22.
After-hours trading shows how investors are pricing APMD after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Apnimed, Inc. (APMD) moved from $26,23 to $25,51, representing a decline of 2,76% ($0,73).
The stock traded between $23,13 and $30,22 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 911,86 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 49,0%
APMD is currently trading at $25,51, placing it 49,0% of the way from its 52-week low of $16,12 to its 52-week high of $35,29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).
| Industry | PHARMACEUTICAL PREPARATIONS |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Apnimed, Inc. (APMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.